Q-omics provides the consensus-scored MIR98 profile across patient tissues and cancer cell-line models. MIR98 expression is associated with patient survival in 15 of 34 cancer types, with the highest sampling consensus in LUSC. Among the 18 cancer types available for tumor–normal comparison, MIR98 is differentially expressed in 3, with the highest sampling consensus in STAD. Additionally, MIR98 RNA expression shows 10,577 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight LUSC, STAD, and THYM as cancer lineages where MIR98 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR98 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR98 survival associations across molecular data types. MIR98 RNA expression shows survival associations in the most cancer types (15). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR98 RNA expression–survival associations across cancer types. High MIR98 expression shows unfavorable associations in LUSC, PAAD and MESO, but favorable associations in LIHC, STAD and THCA. The LUSC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LUSC as the clearest survival context for MIR98 RNA expression.
This table summarizes MIR98 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 3. The strongest signals are observed in STAD for RNA.
This table ranks reproducible tumor–normal expression differences for MIR98. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR98 shows higher tumor expression in STAD, LIHC and HNSC. The STAD box plot shows higher MIR98 RNA expression in tumor versus normal tissue (log2 FC = +0.584, t-test p = .019).
This table shows molecular features associated with MIR98 in patient tissues and cancer cell lines. In patient samples, MIR98 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
